Delivery Order SPE2DX22D0010-SPE2D825FEX01
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$8.8K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a ceiling value of $1,051.36 and a period of performance ending on March 7, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a total ceiling value of $1,971.30 and a completion date of January 16, 2025. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 and awarded to AmerisourceBergen by the DLA,...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Quillivant XR 25 mg/5 ml suspension medication, with a ceiling value of $1,870.98 and a period of performance through August 2024. The contract is structured as a firm fixed price delivery order, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $1,310.10, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml containers. The contract is a firm fixed price delivery order with a period of performance through January 8, 2025. This award is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a 60 ml medication. The firm-fixed-price delivery order has a ceiling value of $1,846.75 and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of QUILLIVANT XR ORAL SUSP 60ML 5MG/ML, a pharmaceutical product, with a ceiling value of $4,822.86 and a completion date of January 29, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract, valued at $1,933.39, is a delivery order with a firm fixed price. The ultimate completion date is February 26, 2025. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a Firm Fixed Price (FFP) pricing type and a ceiling value of $2,826.42. The contract has a period of performance through March 13, 2025. This award is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR, a 25 mg/5 ml suspension drug, with a ceiling value of $1,445.62 and a period of performance through January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract is a delivery order with a firm fixed price of $1,524.36 and a completion date of June 7, 2023. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides medical supplies and pharmaceuticals to military and federal healthcare facilities. AmerisourceBergen holds a substantial...